Article Sidebar

PDF
Date Published: 20/04/2023
Abstract Views: 682
Views PDF: 270
DOI: https://doi.org/10.51298/vmj.v525i1B.5106
Issue
Vol. 525 No. 1B (2023)
Section
Các bài báo
How to Cite
Nguyễn, V. T. ., Đặng, Q. T., Nguyễn, A. T. ., & Lưu , T. V. . (2023). THROMBOCYTOPENIA IN PATIENTS WITH SEPSIS. Vietnam Medical Journal, 525(1B). https://doi.org/10.51298/vmj.v525i1B.5106

THROMBOCYTOPENIA IN PATIENTS WITH SEPSIS

Văn Trọng Nguyễn1, Quốc Tuấn Đặng1,2,, Anh Tuấn Nguyễn2, Tuấn Việt Lưu 2
1 Bach Mai hospital
2 Hanoi medical university

Main Article Content

Abstract

Study objectives: Describe the prevalence, severity, and course of platelets of patients with sepsis in the intensive care center. Study subjects: 307 thrombocytopenia patients with sepsis at Bach Mai Hospital's Intensive Care Center from September 2021 to July 2022. Methods: This is a descriptive study. Results: A total of 307 patients were included in the study. Pneumonia was the most common infection (40%). The median duration of thrombocytopenia was 6,4 days. Most patients with moderate and severe thrombocytopenia. Mortality/Severe rates of thrombocytopenia in sepsis/septic shock with DIC were statistically significantly different from those without DIC with OR =3,064, P < 0.05. Conclusion: Thrombocytopenia is common and is associated with worse clinical outcomes. Thus, thrombocytopenia at admission or the onset of septic shock in septic shock patients can be used as an early marker for risk stratification to identify patients at risk of complicated clinical course and increased mortality. Clinicians should be aggressive in diagnosing and treating the cause of thrombocytopenia in septic shock patients in view of their clinical outcome.

Article Details

Keywords

Thrombocytopenia, intensive care unit, sepsis, sepsis shock

References

1. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810. doi:10.1001/jama.2016.0287
2. de Stoppelaar SF, van ’t Veer C, van der Poll T. The role of platelets in sepsis. Thromb Haemost. 2014;112(4):666-677. doi:10.1160/ TH14-02-0126
3. Williamson DR, Lesur O, Tétrault JP, Nault V, Pilon D. Thrombocytopenia in the critically ill: prevalence, incidence, risk factors, and clinical outcomes. Can J Anaesth J Can Anesth. 2013; 60(7):641-651. doi:10.1007/s12630-013-9933-7
4. Vanderschueren S, De Weerdt A, Malbrain M, et al. Thrombocytopenia and prognosis in intensive care. Crit Care Med. 2000;28(6):1871-1876. doi:10.1097/00003246-200006000-00031
5. Venkata C, Kashyap R, Farmer JC, Afessa B. Thrombocytopenia in adult patients with sepsis: incidence, risk factors, and its association with clinical outcome. J Intensive Care. 2013;1(1):9. doi:10.1186/2052-0492-1-9
6. Sharma B, Sharma M, Majumder M, Steier W, Sangal A, Kalawar M. Thrombocytopenia in septic shock patients--a prospective observational study of incidence, risk factors and correlation with clinical outcome. Anaesth Intensive Care. 2007;35(6):874-880. doi:10.1177/0310057X0703500604
7. Aird WC. The hematologic system as a marker of organ dysfunction in sepsis. Mayo Clin Proc. 2003; 78(7):869-881. doi:10.4065/78.7.869
8. Zarychanski R, Houston DS. Assessing thrombocytopenia in the intensive care unit: the past, present, and future. Hematol Am Soc Hematol Educ Program. 2017;2017(1):660-666.
9. Zhang M ka, Xu T qi, Zhang X jing, et al. Thrombocytopenia in 737 adult intensive care unit patients: A real-world study of associated factors, drugs, platelet transfusion, and clinical outcome. SAGE Open Med. 2020;8:205031212095890. doi:10.1177/2050312120958908
10. Aird WC. The hematologic system as a marker of organ dysfunction in sepsis. Mayo Clin Proc. 2003;78(7):869-881. doi:10.4065/78.7.869
11. Kitchens CS. Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC). Hematol Am Soc Hematol Educ Program. Published online 2009:240-246. doi:10.1182/ asheducation-2009.1.240